Skip to main content
. 2017 Nov 23;29(2):431–438. doi: 10.1093/annonc/mdx754

Figure 3.

Figure 3.

Overall survival—arm 1: i.v. carboplatin + i.v. paclitaxel; arm 2: i.p. cisplatin + i.v./i.p. paclitaxel; arm 3: i.p. carboplatin + i.v./i.p. paclitaxel.